[CLINICAL INVESTIGATION WITH INJECTABLE BETAMETHASONE].
D001623:Betamethasone; D003877:Dermatitis, Contact; D003880:Dermatology; D003875:Drug Eruptions; D004342:Drug Hypersensitivity; D006634:Histamine H1 Antagonists; D006967:Hypersensitivity; D007267:Injections; D007299:Insect Bites and Stings; D009450:Neurodermatitis; D010392:Pemphigus; D010406:Penicillins / Q000009:adverse effects* / Q000633:toxicity*; D011565:Psoriasis; D014116:Toxicology; D014581:Urticaria
D006634:Histamine H1 Antagonists; D010406:Penicillins; D001623:Betamethasone
ANTIHISTAMINICS; BETAMETHASONE; DERMATITIS MEDICAMENTOSA; DERMATITIS, CONTACT; DERMATOLOGY; DRUG HYPERSENSITIVITY; HYPERSENSITIVITY; INJECTIONS; INSECT BITES AND STINGS; NEURODERMATITIS; PEMPHIGUS; PENICILLIN TOXICOLOGY; PSORIASIS; TOXICOLOGIC REPORT; URTICARIA
INVESTIGACI'ON CL'INICA CON BETAMETASONA INYECTABLE.